Oncopeptides AB
ONCO.ST$1.12B
Small CapNASDAQBiotechnology🇺🇸North America75 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ONCO.ST News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations |
|---|---|---|---|
Melphalan flufenamide (Melflufen) | Phase 2 | Multiple Myeloma | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply